Recombinant CD1a antibody (CF®640R)
Quick Overview for Recombinant CD1a antibody (CF®640R) (ABIN7650900)
Target
See all CD1a AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Purpose
 - CD1a / HTA1 (Mature Langerhans Cells Marker) (rC1A/711), CF640R conjugate
 - 
                                            
Characteristics
 - At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa).Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
 - 
                                            
Immunogen
 - Recombinant full-length human CD1a protein
 - 
                                            
Isotype
 - IgG1, kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Comment
 - 
                        
Positive Control: MOLT-4 cells. Paracortex in a tonsil or a reactive lymph node.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Concentration
 - 0.1 mg/mL
 - 
                                            
Buffer
 - PBS, 0.1 % BSA, 0.05 % azide
 - 
                                            
Preservative
 - Sodium azide
 - 
                                            
Precaution of Use
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Handling Advice
 - Protect from light
 - 
                                            
Storage
 - 4 °C
 - 
                                            
Storage Comment
 - 
                        
Stable at room temperature or 37°C for 7 days.
Protect from light
Store at 2 to 8°C. Protect fluorescent conjugates from light
 - 
                                            
Expiry Date
 - 24 months
 
 - 
                                            
 - 
    
- CD1a
 - 
                                            
Alternative Name
 - CD1a
 - 
                                            
Background
 - 
                        
Synonyms: Cortical thymocyte antigen CD1A, Epidermal dendritic cell marker CD1a, FCB6, HTA1, T cell surface antigen T6 / Leu 6, T-Cell Surface Glycoprotein CD1A
Gene Symbol: CD1A
Tissue Expression: Antigen presenting cells
 - 
                                            
Molecular Weight
 - 49 kDa
 - 
                                            
Gene ID
 - 909
 - 
                                            
UniProt
 - P06126
 - 
                                            
Pathways
 - Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
 
Target
 -